Benzinga | Mar 18, 2021 07:04AM EDT

Galmed Pharmaceuticals Q4 EPS $(0.48) Misses $(0.36) Estimate

Galmed Pharmaceuticals (NASDAQ:GLMD) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate of $(0.36) by 33.33 percent. This is a 23.08 percent decrease over losses of $(0.39) per share from the same period last year.